Meletios Therapeutics
PrivateLast Round
Grant
Jun 29, 2023
Total Funding Raised
$8.45M
Company Overview
Meletios Therapeutics operates in Healthcare & Life Sciences and is based in Lyon. Its latest recorded funding round was a Grant round in June 2023.
Meletios Therapeutics is a biotechnology company that develops broad-spectrum antiviral treatments targeting host mechanisms to combat current and emerging viral infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Meletios Therapeutics Comparables
Compare Meletios Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atriva Therapeutics GmbH | 83% | |
| Astremiha Therapeutics | 80% | |
| Kimer Med | 79% |
For institutional investors. Book with your work email.
Meletios Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 29, 2023 | ||||
| Grant | Jun 15, 2022 | ||||
| Seed | Sep 1, 2021 |
For institutional investors. Book with your work email.
Meletios Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 15, 2022
Secured $2.66M from the European Innovation Council Fund.
- Sep 1, 2021
$4.5M raised in Seed round.
For institutional investors. Book with your work email.
Meletios Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Meletios Therapeutics's valuation, stock price, and market status.
Is Meletios Therapeutics a public or private company?
Meletios Therapeutics is a private company.
What is the current stock price of Meletios Therapeutics?
Meletios Therapeutics is a private company, so its shares have no public market price. Caplight tracks Meletios Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Meletios Therapeutics worth (valuation)?
Valuation information for Meletios Therapeutics is not publicly available.
Can I buy Meletios Therapeutics stock?
Meletios Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Meletios Therapeutics's last funding round?
Meletios Therapeutics's most recent funding round was Grant on June 29, 2023.
Who are the main investors in Meletios Therapeutics?
Key investors in Meletios Therapeutics include European Innovation Council Fund, Bpifrance.
Will Meletios Therapeutics IPO soon?
No public IPO plans have been announced for Meletios Therapeutics.
How can I track Meletios Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Meletios Therapeutics's shares on secondary markets.